ESC Congress 2017

26 - 30 August 2017, Barcelona - Spain

Session Details

Hot Line: Late-Breaking Clinical Trials 4
Tue 29 Aug 08:30 - 10:00 Miscellaneous Hot Line Barcelona - Main Auditorium
Chairpersons: Michel KOMAJDA (Paris, France), Hector BUENO (Madrid, Spain)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:304728Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trialMartin LANDRAY (Oxford, United Kingdom)
08:404729Discussant review: Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trialJohn CHAPMAN (Saint Maur, France)
08:454730Panel discussion. 
08:514731Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY studyHiroshi ITOH (Tokyo, Japan)
09:014732Discussant review: Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY studyEva PRESCOTT (Copenhagen, Denmark)
09:064733Panel discussion. 
09:124734Withdrawn - Exercise training in diastolic heart failure (Ex-DHF): a multicenter, prospective, randomized, controlled, parallel group trial 
09:124737Catheter Ablation compared with optimized Pharmacological Therapy for Atrial Fibrillation, a randomized multicentre study of quality of life and implantable cardiac monitoring after 12 month follow-upCarina BLOMSTROM-LUNDQVIST (Uppsala, Sweden)
09:224738Discussant review: Catheter Ablation compared with optimized Pharmacological Therapy for Atrial Fibrillation, a randomized multicentre study of quality of life and implantable cardiac monitoring after 12 month follow-upNassir MARROUCHE (Salt Lake City, United States of America)
09:274739Panel discussion. 
09:334740Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation (The REHEARSE-AF study) Julian HALCOX (Swansea, United Kingdom)
09:434741Discussant review: Assessment of REmote HEArt Rhythm Sampling using the AliveCor heart monitor to scrEen for Atrial Fibrillation.Christophe LECLERCQ (Rennes, France)
09:484742Panel discussion.